Delivery Order SPE2DB24D8002-SPE2DB25FJNAH
Award Date
1/22/25
Potential Completion Date
1/23/25
Potential Value
$15K
Federal Agency
Defense Logistics Agency
Awardee
Dakota Drug, Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Anoka, MN, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $2,788.46 firm fixed-price delivery order is for the supply of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The contract has an ultimate completion date of April 4, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense. The company holds a...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $1,807.32 firm fixed-price delivery order is for the supply of Losartan-HCTZ 100-12.5 mg tablets. This order is part of a larger $999,999,999.00 indefinite delivery contract (SPE2DB24D8001) held by Dakota Drug, Inc. under the DLA Troop Support Medical's ECAT Generation V Program, which procures commercial medical equipment,...
This federal contract award to Dakota Drug, Inc., a self-certified small disadvantaged business, was issued by the Defense Logistics Agency (DLA) for the delivery of 4566854010 - LOSARTAN-HCTZ 100-25 MG TAB 90S. The contract has a ceiling value of $1,454.42 and a period of performance through January 8, 2025. This award is part of a larger Indefinite Delivery Contract (IDC) held by Dakota Drug, Inc. with the DLA, valued at $999,999,999.00, which allows the company to provide a comprehensive...
This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The contract, valued at $8,439.71, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets in 90-count packages. The contract has an ultimate completion date of March 6, 2025. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare equipment to the U.S. Department of Defense through the DLA....
This federal contract award, identified as SPE2DB24D8003|SPE2DB25FJTJJ, was issued by the Defense Logistics Agency (DLA) for the delivery of Losartan-HCTZ 100-25 mg tablets in 90-count packages. The $2,777.68 fixed-price delivery order was awarded to Dakota Drug, Inc., a self-certified small disadvantaged business, on November 26, 2024, with a completion date of November 27, 2024. Dakota Drug, Inc. is a key supplier to the DLA Troop Support Medical division, holding a significant $999,999,999.00...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the delivery of Losartan-HCTZ 100-25 mg tablets. The contract has a ceiling value of $1,747.92 and a completion date of February 11, 2025. The contract is a firm fixed-price delivery order, which is not associated with a set-aside program. Dakota Drug, Inc. is a key supplier of pharmaceutical products, medical supplies, and healthcare...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business, for the supply of Losartan-HCTZ 100-25 mg tablets. The contract has a firm fixed price of $22,937.69 and a period of performance through March 5, 2025. This award is not designated as a set-aside contract. Dakota Drug, Inc. holds a significant Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999.00, as part of the DLA Troop Support...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $18,462.43 firm fixed-price contract is for the delivery of 4566847986 LOSARTAN-HCTZ 100-25 MG TAB 90S to support U.S. Armed Forces medical operations. The contract has an ultimate completion date of January 7, 2025 and is not a set-aside. Dakota Drug, Inc. is also the prime contractor on a larger $999,999,999.00 Indefinite Delivery Contract...
This federal contract award with ID SPE2DB24D8002|SPE2DB25FJMZV was issued by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business. The $6,370.93 firm fixed price delivery order is for the supply of 4566996747 - LOSARTAN-HCTZ 100-25 MG TAB 90S, with a period of performance through January 22, 2025. This award is part of Dakota Drug, Inc.'s larger $999,999,999.00 Indefinite Delivery Contract SPE2DB24D8001 under the DLA Troop Support Medical's ECAT...
This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) to Dakota Drug, Inc., a self-certified small disadvantaged business located in Anoka, Minnesota. The contract, with a ceiling value of $5,037.52, is for the delivery of Losartan-HCTZ 100-12.5 mg tablets over the performance period ending on April 30, 2025. This delivery order is part of Dakota Drug, Inc.'s larger Indefinite Delivery Contract (IDC) with the DLA, identified as SPE2DB24D8001, valued at...